Nonhuman primate models of intrauterine cytomegalovirus infection

ILAR Journal

Volumn 47, Issue 1, 2006, Pages 49-64

  Barry, Peter A ^a   Lockridge, Kristen M ^b,e   Salamat, Shariar ^b,f   Tinling, Steven P ^b   Yue, Yujuan ^b   Zhou, Shan Shan ^b   Gospe Jr , Sidney M ^c   Britt, William J ^d   Tarantal, Alice F ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d University of Alabama at Birmingham   (United States)

^e BECKMAN COULTER INC   (United States)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Congenital infection; Cytomegalovirus; Immune ontogeny; Intrauterine pathogenesis; Nonhuman primate model of HCMV pathogenesis; Rhesus macaque; Sensorineural deficits; Transplacental transfer of maternal immunoglobulin G

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CIDOFOVIR; CYTOMEGALOVIRUS ANTIBODY; CYTOMEGALOVIRUS ANTIGEN PP65; CYTOMEGALOVIRUS VACCINE; GANCICLOVIR; IMMUNOGLOBULIN G; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY TITER; CENTRAL NERVOUS SYSTEM DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG EFFICACY; FETOTOXICITY; FETUS DEVELOPMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOGLOBULIN PRODUCTION; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INTRAUTERINE INFECTION; MACACA; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY; PREVALENCE; PRIMATE; REVIEW; RISK FACTOR; VACCINATION; VERTICAL TRANSMISSION; VIRUS GENOME; VIRUS IMMUNITY; VIRUS PATHOGENESIS; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION;

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5; MACACA; MACACA MULATTA; PRIMATES;

EID: 29544432166     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.47.1.49     Document Type: Review

References (109)

1. Aase JM, Noren GR, Reddy DV, St. Geme Jr. JW. 1972. Mumps-virus infection in pregnant women and the immunologic response of their offspring. N Engl J Med 286:1379-1382.
2. Adler SP. 1988. Molecular epidemiology of cytomegalovirus: Viral transmission among children attending a day care center, their parents, and caretakers. J Pediatr 112:366-372.
3. Alcendor DJ, Barry PA, Pratt-Lowe E, Luciw PA. 1993. Analysis of the rhesus cytomegalovirus immediate-early gene promoter. Virology 194: 815-821.
4. Alford CA, Britt WJ. 1993. Cytomegalovirus. In: Roizman B, Whitley RJ, Lopez C, eds. The Human Herpesviruses. New York: Raven Press, Ltd. p 227-255.
5. Alford CA, Stagno S, Pass RF, Britt WJ. 1990. Congenital and perinatal cytomegalovirus infections. Rev Infect Dis S745-S753.
6. Andrade MR, Yee J, Barry PA, Spinner A, Roberts JA, Cabello H, Leite JP, Lerche NW. 2003. Prevalence of antibodies to selected viruses in a long-term closed breeding colony of thesus macaques (Macaca mulatta) in Brazil. Am J Primatol 59:123-128.
7. Arvin AM, Fast P, Myers M, Plotkin S, Rabinovich R. 2004. Vaccine development to prevent cytomegalovirus disease: Report from the National Vaccine Advisory Committee. Clin Infect Dis 39:233-239.
8. Asher DM, C. J. Gibbs J, Lang DJ, Gadjusek DC, Chanock RM. 1974. Persistent shedding of cytomegalovirus in the urine of healthy rhesus monkeys. Proc Soc Exp Biol Med 145:794-801.
9. Aynaud O, Poveda JD, Huynh B, Guillemotonia A, Barrasso R. 2002. Frequency of herpes simplex virus, cytomegalovirus and human papillomavirus DNA in semen. Int J STD AIDS 13:547-550.
10. Barkovich AJ, Lindan CE. 1994. Congenital cytomegalovirus infection of the brain: Imaging analysis and embryologic considerations. AJNR 15:703-715.
11. Barry PA, Alcendor DJ, Power MD, Kerr H, Luciw PA. 1996. Nucleotide sequence and molecular analysis of the rhesus cytomegalovirus immediate-early gene and the UL121-117 open reading frames. Virology 215:61-72.
12. Bolovan-Fritts CA, Mocarski ES, Wiedeman JA. 1999. Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 93:394-398.
13. Boppana SB, Britt WJ. 1995. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 171:1115-1121.
14. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. 1999. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 104:55-60.
15. Caceres VM, Strebel PM, Sutter RW. 2000. Factors determining prevalence of maternal antibody to measles virus throughout infancy: A review. Clin Infect Dis 31:110-119.
16. Chang WL, Tarantal AF, Zhou SS, Borowsky AD, Barry PA. 2002. A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques. J Virol 76:9493-9504.
17. Coe CL, Kemnitz JW, Schneider ML. 1993. Vulnerability of placental antibody transfer and fetal complement synthesis to disturbance of the pregnant monkey. J Med Primatol 22:294-300.
18. Dobbins JG, Stewart JA, Demmler GJ. 1992. Surveillance of congenital cytomegalovirus disease, 1990-1991. Collaborating Registry Group. MMWR CDC Surveill Sum 41:35-39.
19. Dworsky M, Yow M, Stagno S, Pass RF, Alford C. 1983. Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 72:295-299.
20. Egawa H, Inomata Y, Uemoto S, Asonuma K, Kiuchi T, Fujita S, Hayashi M, Matamoros MA, Itou K, Tanaka K. 2001. Biliary anastomotic complications in 400 living related liver transplantations. World J Surg 25:1300-1307.
21. Eitzman BV. 1970. Immunoglobulin levels in the Macaca mulatta. Folia Primatol (Basel) 12:313-316.
22. Englund J, Glezen WP, Piedra PA. 1998. Maternal immunization against viral disease. Vaccine 16:1456-1463.
23. Fowler KB, Stagno S, Pass RF. 2003. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 289:1008-1011.
24. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. 1992. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326:663-667.
25. Fujimoto K, Hiyaoka A, Cho F, Honjo S. 1988. Age-related changes of immunoglobulin levels in African green monkey (Cercopithecus aethiops). J Med Primatol 17:85-93.
26. Fujimoto K, Terao K, Cho F, Honjo S. 1983a. Immunoglobulins and measles antibody in sera of newborn cynomolgus monkeys and in milk of their mothers. Jpn J Med Sci Biol 36:209-214.
27. Fujimoto K, Terao K, Cho F, Honjo S. 1983b. The placental transfer of IgG in the cynomolgus monkey. Jpn J Med Sci Biol 36:171-176.
28. Gautheret-Dejean A, Aubin JT, Poirel L, Huraux JM, Nicolas JC, Rozenbaum W, Agut H. 1997. Detection of human Betaherpesvirinae in saliva and urine from immunocompromised and immunocompetent subjects. J Clin Microbiol 35:1600-1603.
29. Griffiths P. 2004. Cytomegalovirus infection of the central nervous system. Herpes 11(Suppl 2):95A-104A.
30. Hahn G, Jores R, Mocarski ES. 1998. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A 95:3937-3942.
31. Hamprecht K, Vochem M, Baumeister A, Boniek M, Speer CP, Jahn G. 1998. Detection of cytomegaloviral DNA in human milk cells and cell free milk whey by nested PCR. Virol Meth 70:167-176.
32. Hansen SG, Strelow LI, Franchi DC, Anders DG, Wong SW. 2003. Complete sequence and genomic analysis of rhesus cytomegalovirus. J Virol 77:6620-6636.
33. Hara T, Ohashi S, Yamashita Y, Abe T, Hisaeda H, Himeno K, Good RA, Takeshita K. 1996. Human V delta 2+ gamma delta T-cell tolerance to foreign antigens of Toxoplasma gondii. Proc Natl Acad Sci U S A 93:5136-5140.
34. Hayward JC, Titelbaum DS, Clancy RR, Zimmerman RA. 1991. Lissencephaly-pachygyria associated with congenital cytomegalovirus infection. J Child Neurol 6:109-114.
35. Hicks T, Fowler K, Richardson M, Dahle A, Adams L, Pass R. 1993. Congenital cytomegalovirus infection and neonatal auditory screening. J Pediatr 123:779-782.
36. Hoar R, Monie I. 1981. Comparative development of specific organ systems. In: Kimmel C, Buelke-Sam J, eds. Developmental Toxicology. New York: Raven Press. p 13-33.
37. Howard MR, Whitby D, Bahadur G, Suggett F, Boshoff C, Tenant-Flowers M, Schulz TF, Kirk S, Matthews S, Weller IV, Tedder RS, Weiss RA. 1997. Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. Aids 11:F15-F19.
38. Huff JE, Eberle R, Capitanio J, Zhou S-S, Barry PA. 2003. Differential detection of B virus and rhesus cytomegalovirus in rhesus macaques. J Gen Virol 84:83-92.
39. Huff JL, Barry PA. 2003. B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: Potential for zoonotic disease. Emerg Infect Dis 9:246-250.
40. Istas AS, Demmler GJ, Dobbins JG, Stewart JA. 1995. Surveillance for congenital cytomegalovirus disease: A report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis 20:665-670.
41. Jauniaux E, Jurkovic D, Gulbis B, Liesnard C, Lees C, Campbell S. 1995. Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy. Hum Reprod 10:3297-3300.
42. Jones T, Mohr U, Hunt R. 1993. Nonhuman Primates I and II. Berlin: Springer-Verlag.
43. Kashiwagi Y, Nemoto S, Hisashi, Kawashima, Takekuma K, Matsuno T, Hoshika A, Nozaki-Renard J. 2001. Cytomegalovirus DNA among children attending two day-care centers in Tokyo. Pediatr Int 43:493-495.
44. Kaur A, Hale CL, Noren B, Kassis N, Simon MA, Johnson RP. 2002. Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: Inverse relationship with CMV viremia. J Virol 76:3646-3658.
45. Kaur A, Kassis N, Hale CL, Simon M, Elliott M, Gomez-Yafal A, Lifson JD, Desrosiers RC, Wang F, Barry P, Mach M, Johnson RP. 2003. Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS. J Virol 77: 5749-5758.
46. Kaur A, Rosenzweig M, Johnson RP. 2000. Immunological memory and acquired immunodeficiency syndrome pathogenesis. Philos Trans R Soc Lond B Biol Sci 355:381-390.
47. Kondo K, Xu J, Mocarski ES. 1996. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci U S A 93:11137-11142.
48. Kravitz RH, Sciabica KS, Cho K, Luciw PA, Barry PA. 1997. Cloning and characterization of the rhesus cytomegalovirus glycoprotein B. J Gen Virol 78:2009-2013.
49. Larsson S, Soderberg-Naucler C, Moller E. 1998. Productive cytomegalovirus (CMV) infection exclusively in CD13-posifive peripheral blood mononuclear cells from CMV-infected individuals: Implications for prevention of CMV transmission. Transplantation 65:411-415.
50. Li RY, Tsutsui Y. 2000. Growth retardation and microcephaly induced in mice by placental infection with murine cytomegalovirus. Teratology 62:79-85.
51. Lockridge KM, Sequar G, Zhou SS, Yue Y, Mandell CM, Barry PA. 1999. Pathogenesis of experimental rhesus cytomegalovirus infection. J Virol 73:9576-9583.
52. Lockridge KM, Zhou SS, Kravitz RH, Johnson JL, Sawai ET, Blewett EL, Barry PA. 2000. Primate cytomegaloviruses encode and express an IL-10-like protein. Virol 268:272-280.
53. London WT, Martinez AJ, Houff SA, Wallen WC, Curfman BL, Traub RG, Sever JL. 1986. Experimental congenital disease with simian cytomegalovirus in rhesus monkeys. Teratology 33:323-331.
54. London WT, Sever JL, Madden DL, Henrickson RV, Gravell M, Maul DH, Dalakas MC, Osborn KG, Houff SA, Gardner MB. 1983. Experimental transmission of simian acquired immunodeficiency syndrome (SAIDS) and Kaposi-like skin lesions. Lancet 2:869-873.
55. Lowell JA, Stratta RJ, Morton JJ, Kolbeck PC, Taylor RJ. 1994. Invasive cytomegalovirus infection in a renal transplant ureter after combined pancreas-kidney transplantation: An unusual cause of renal allograft dysfunction. J Urol 152:1546-1548.
56. Lynch L, Daffos F, Emanuel D, Giovangrandi Y, Meisel R, Forestier F, Cathomas G, Berkowitz L. 1991. Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol 165:714-718.
57. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC. 1992. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170-178.
58. Makori N, Tarantal AF, Lu FX, Rourke T, Marthas ML, McChesney MB, Hendrickx AG, Miller CJ. 2003. Functional and morphological development of lymphoid tissues and immune regulatory and effector function in rhesus monkeys: Cytokine-secreting cells, immunoglobulin-secreting cells, and CD5(+) B-1 cells appear early in fetal development. Clin Diagn Lab Immunol 10:140-153.
59. Mansat A, Mengelle C, Chalet M, Boumzebra A, Mieusset R, Puel J, Prouheze C, Segondy M. 1997. Cytomegalovirus detection in cryopreserved semen samples collected for therapeutic donor insemination. Hum Reprod 12:1663-1666.
60. McCormick AL, Skaletskaya A, Barry PA, Mocarski ES, Goldmacher VS. 2003. Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses. Virology 221-233.
61. Minamishima Y, Graham BJ, Benyesh-Melnick M. 1971. Neutralizing antibodies to cytomegaloviruses in normal simian and human sera. Infect Immun 4:368-373.
62. Mocarski ESJ. 1993. Cytomegalovirus biology and replication. In: Roizman B, Whitley RJ, Lopez C, eds. The Human Herpesviruses. New York: Raven Press, Ltd. p 173-226.
63. Moe JB, Osburn BI. 1983. Fetal and maternal immunologic manifestations of intrauterine adenovirus SV-20 infection. Vet Immunol Immunopathol 4:319-332.
64. Mussi-Pinhata MM, Pinto PC, Yamamoto AY, Berencsi K, de Souza CB, Andrea M, Duarte G, Jorge SM. 2003. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates. J Med Virol 69:232-239.
65. Nigida SM, Falk LA, Wolfe LG, Deinhardt F. 1979. Isolation of a cytomegalovirus from salivary glands of white-lipped marmosets (Saguinus fuscicollis). Lab Anim Sci 29:53-60.
66. Nigro G, Anceschi MM, Cosmi EV. 2003. Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection. Bjog 110:572-577.
67. North TW, Sequar G, Townsend LB, Drach JC, Barry PA. 2004. Rhesus cytomegalovirus is similar to human cytomegalovirus in susceptibility to benzimidizole nucleosides. Antimicrob Agents Chemother 48:2760-2765.
68. Penfold ME, Schmidt TL, Dairaghi DJ, Barry PA, Schall TJ. 2003. Characterization of the rhesus cytomegalovirus US28 locus. J Virol 77: 10404-10413.
69. Pereyra F, Rubin RH. 2004. Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients. Curr Opin Infect Dis 17:357-361.
70. Perlman JM, Argyle C. 1992. Lethal cytomegalovirus infection in preterm infants: Clinical, radiological, and neuropathological findings. Ann Neurol 31:64-68.
71. Perot K, Walker CM, Spaete RR. 1992. Primary chimpanzee skin fibroblast cells are fully permissive for human cytomegalovirus replication. J Gen Virol 73:3281-3284.
72. Rakic P. 1988. Specification of cerebral cortical areas. Science 241:170-176.
73. Rayfield LS, Brent L, Boylston A, Rodeck CH, Modell B. 1987. Human fetal lymphocytes require T cell growth factors for cytotoxic responses. Clin Exp Immunol 69:451-458.
74. Rayfield LS, Brent L, Rodeck CH. 1980. Development of cell-mediated lympholysis in human foetal blood lymphocytes. Clin Exp Immunol 42:561-570.
75. Reyes C, Pereira S, Warden MJ, Sills J. 1997. Cytomegalovirus enteritis in a premature infant. J Pediatr Surg 32:1545-1547.
76. Schelonka RL, Infante AJ. 1998. Neonatal immunology. Semin Perinatol 22:2-14.
77. Schelonka RL, Raaphorst FM, Infante D, Kraig E, Teale JM, Infante AJ. 1998. T cell receptor repertoire diversity and clonal expansion in human neonates. Pediatr Res 43:396-402.
78. Schleiss MR. 2005. Nonprimate models of congenital cytomegalovirus (CMV) infection: Gaining insight into pathogenesis and prevention of disease in newborns. ILAR J 47:65-72.
79. Sequar G, Britt WJ, Lakeman FD, Lockridge KM, Tarara RP, Canfield DR, Zhou SS, Gardner MB, Barry PA. 2002. Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: Pathogenesis. J Virol 76:7661-7671.
80. Simister NE. 2003. Placental transport of immunoglobulin G. Vaccine 21:3365-3369.
81. Soderberg-Naucler C, Fish KN, Nelson JA. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126.
82. Soderberg-Naucler C, Nelson JY. 1999. Human cytomegalovirus latency and reactivation - A delicate balance between the virus and its host's immune system. Intervirology 42:314-321.
83. Soderberg-Naucler C, Streblow DN, Fish KN, Allan-Yorke J, Smith PP, Nelson JA. 2001. Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol 75:7543-7554.
84. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, Veren DA, Page F, Alford CA. 1986. Primary cytomegalovirus infection in pregnancy: Incidence, transmission to fetus, and clinical outcome. JAMA 256:1904-1908.
85. Stagno S, Pass RF, Dworsky ME, Henderson RE, Moore EG, Walton PD, Alford CA. 1982. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med 306:945-949.
86. Stagno S, Reynolds D, Tsiantos A, Fuccillo DA, Smith R, Tiller M, Alford CA, Jr. 1975. Cervical cytomegalovirus excretion in pregnant and nonpregnant women: Suppression in early gestation. J Infect Dis 131:522-527.
87. Stiehm ER. 1975. Fetal defense mechanisms. Am J Dis Child 129:438-443.
88. Swanson R, Bergquam E, Wong SW. 1998. Characterization of rhesus cytomegalovirus genes associated with anti-viral susceptibility. Virology 240:338-348.
89. Tanimura T, Tanioka Y. 1975. Comparison of embryonic and foetal development in man and rhesus monkey. Lab Anim Hndbk 6:205-233.
90. Tarantal A. 2005. Ultrasound imaging in rhesus (Macaca mulatta) and long-tailed (Macaca fascicularis) macaques: Reproductive and Research Applications. In: Wolfe-Coote S, ed. The Laboratory Primate: Handbook of Experimental Animals. San Diego: Elsevier (In press).
91. Tarantal AF. 1990. Interventional ultrasound in pregnant macaques: Embryonic/fetal applications. J Med Primatol 19:47-58.
92. Tarantal AF, Castillo A, Ekert JE, Bischofberger N, Martin RB. 2002. Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta). J Acquir Immune Defic Syndr 29:207-220.
93. Tarantal AF, Gargosky SE. 1995. Characterization of the insulin-like growth factor (IGF) axis in the serum of maternal and fetal macaques (Macaca mulatta and Macaca fascicularis). Growth Reg 55:190-198.
94. Tarantal AF, Hendrickx AG. 1988a. Prenatal growth in the cynomolgus and rhesus macaque (Macaca fascicularis and Macaca mulatta): A comparison by ultrasonography. Am J Primatol 15:309-323.
95. Tarantal AF, Hendrickx AG. 1988b. Use of ultrasound for early pregnancy detection in the rhesus and cynomolgus macaque (Macaca mulatta and Macaca fascicularis). J Med Primatol 17:105-112.
96. Tarantal AF, Marthas ML, Shaw JP, Cundy K, Bischofberger N. 1999. Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): Safety and efficacy studies. J Acquir Immune Defic Syndr Hum Retrovirol 20:323-333.
97. Tarantal AF, Salamat S, Britt WJ, Luciw PA, Hendrickx AG, Barry PA. 1998. Neuropathogenesis induced by rhesus cytomegalovirus in fetal rhesus monkeys (Macaca mulatta). J Infect Dis 177:446-450.
98. Tarantal AF, Spanggord RJ, G. HA. 1994. Pre- and postnatal treatment of the rhesus macaque (Macaca mulatta) with azidothymidine: I. Fetal studies. Ped AIDS and HIV Infect: Fetus to Adolesc 5:10-19.
99. Taylor GH. 2003. Cytomegalovirus. Am Fam Physician 67:519-524.
100. Taylor-Weideman J, Sissons JGP, Borysiewicz LK, Sinclair JH. 1991. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72:2059-2064.
101. Taylor-Wiedeman J, Hayhurst GP, Sissons JGP, Sinclair JH. 1993. Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J Gen Virol 74:265-268.
102. Twickler DM, Perlman J, Maberry MC. 1993. Congenital cytomegalovirus infection presenting as cerebral ventriculomegaly on antenatal sonography. Am J Perinatol 10:404-406.
103. Vogel P, Weigler BJ, Kerr H, Hendrickx A, Barry PA. 1994. Seroepidemiologic studies of cytomegalovirus infection in a breeding population of rhesus macaques. Lab Anim Sci 44:25-30.
104. Weller TH. 1971. The cytomegaloviruses: Ubiquitous agents with protean clinical manifestations (first of two parts). N Engl J Med 285:203-214.
105. Weller TH. 1971. The cytomegaloviruses: Ubiquitous agents with protean clinical manifestations (second of two parts). N Engl J Med 285:267-274.
106. Wennberg RP, Gospe SM, Rhine WD, Seyal M, Saeed D, Sosa G. 1993. Brainstem bilirubin toxicity in the newborn primate may be promoted and reversed by modulating PCO. Pediatr Res 34:6-9.
107. Yue Y, Zhou SS, Barry PA. 2003. Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques. J Gen Virol 84:3371-3379.
108. Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF. 1999. Asymptomatic primary cytomegalovirus infection: Virologic and immunologic features. J Infect Dis 180:702-707.
109. Zhuravskaya T, Maciejewski JP, Netski DM, Bruening E, Mackintosh FR, St Jeor S. 1997. Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: Model of HCMV latency. Blood 90:2482-2491.